4//SEC Filing
Choy Gavin 4
Accession 0001654954-22-001631
CIK 0000109657other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:09 PM ET
Size
5.3 KB
Accession
0001654954-22-001631
Insider Transaction Report
Form 4
Choy Gavin
Acting Chief Financial Officer
Transactions
- Award
Option to purchase Common Stock
2021-12-31+227,500→ 227,500 totalExercise: $3.05Exp: 2031-12-31→ Common Stock (227,500 underlying)
Footnotes (1)
- [F1]33% on the date of grant, 33% on 6/1/22 and 34% on 6/1/23, subject to continued service and subject to full acceleration immediately prior to the consummation of a change of control.
Documents
Issuer
GT Biopharma, Inc.
CIK 0000109657
Entity typeother
Related Parties
1- filerCIK 0001905561
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:09 PM ET
- Size
- 5.3 KB